|
|
||||||||
1 Department of Microbiology and Immunology, University of Newcastle, Newcastle upon Tyne NE2 4HH, UK
2 School of Biosciences, The University of Birmingham, Edgbaston, Birmingham B15 2TT, UK
3 Department of Molecular Mechanisms of Mycobacterial Infections, Institut de Pharmacologie et de Biologie Structurale, CNRS, UMR 5089, 205 route de Narbonne, 31077 Toulouse cedex 4, France
Correspondence
Gurdyal S. Besra
g.besra{at}bham.ac.uk
The genus Rhodococcus is part of the phylogenetic group nocardioform actinomycetes, which also includes the genus Mycobacterium. Members of this phylogenetic group have a characteristic cell envelope structure, which is dominated by various complex lipids. Among these, lipoglycans are of particular interest since mycobacterial lipoarabinomannans are important immunomodulatory molecules that are likely to be involved in the subsequent fate of mycobacterial bacilli once inside phagocytic cells. Rhodococcus ruber is a species closely related to an established opportunistic human pathogen, Rhodococcus equi. This paper reports the isolation and characterization of R. ruber lipoarabinomannan, designated as RruLAM. SDS-PAGE and gas chromatography analyses revealed that RruLAM was of an intermediate size between Mycobacterium tuberculosis lipoarabinomannan and lipomannan. Using a combination of chemical degradation and 1H, 13C-NMR experiments, the carbohydrate structure of RruLAM was unambiguously shown to be composed of a linear (
1
6)-Manp backbone substituted at some O-2 positions by a single t-
-Araf sugar unit. Integration of the anomeric proton signals provided an indication of the degree of branching as approximately 45 %. The RruLAM structure is much simpler than that established for M. tuberculosis lipoarabinomannan but is also different from that determined for the closely related species and opportunistic human pathogen, R. equi. RruLAM was unable to induce the production of TNF-
by either human or murine macrophage cell lines, suggesting that more sophisticated structures, such as phosphoinositol capping motifs, are required for such activity.
, tumour necrosis factor 
K. J. C. G. would like to dedicate this publication to the memory of a close friend, Jonathan D. T. Compton.
This article has been cited by other articles:
![]() |
J. Nigou, T. Vasselon, A. Ray, P. Constant, M. Gilleron, G. S. Besra, I. Sutcliffe, G. Tiraby, and G. Puzo Mannan Chain Length Controls Lipoglycans Signaling via and Binding to TLR2 J. Immunol., May 15, 2008; 180(10): 6696 - 6702. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. V. V. Tatituri, P. A. Illarionov, L. G. Dover, J. Nigou, M. Gilleron, P. Hitchen, K. Krumbach, H. R. Morris, N. Spencer, A. Dell, et al. Inactivation of Corynebacterium glutamicum NCgl0452 and the Role of MgtA in the Biosynthesis of a Novel Mannosylated Glycolipid Involved in Lipomannan Biosynthesis J. Biol. Chem., February 16, 2007; 282(7): 4561 - 4572. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Shi, S. Berg, A. Lee, J. S. Spencer, J. Zhang, V. Vissa, M. R. McNeil, K.-H. Khoo, and D. Chatterjee The Carboxy Terminus of EmbC from Mycobacterium smegmatis Mediates Chain Length Extension of the Arabinan in Lipoarabinomannan J. Biol. Chem., July 14, 2006; 281(28): 19512 - 19526. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. J. C. Gibson, M. Gilleron, P. Constant, B. Sichi, G. Puzo, G. S. Besra, and J. Nigou A Lipomannan Variant with Strong TLR-2-dependent Pro-inflammatory Activity in Saccharothrix aerocolonigenes J. Biol. Chem., August 5, 2005; 280(31): 28347 - 28356. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Gilleron, N. J. Garton, J. Nigou, T. Brando, G. Puzo, and I. C. Sutcliffe Characterization of a Truncated Lipoarabinomannan from the Actinomycete Turicella otitidis J. Bacteriol., February 1, 2005; 187(3): 854 - 861. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. E.B. Lee, W. Li, D. Chatterjee, and R. E. Lee Rapid structural characterization of the arabinogalactan and lipoarabinomannan in live mycobacterial cells using 2D and 3D HR-MAS NMR: structural changes in the arabinan due to ethambutol treatment and gene mutation are observed Glycobiology, February 1, 2005; 15(2): 139 - 151. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. J. C. Gibson, M. Gilleron, P. Constant, T. Brando, G. Puzo, G. S. Besra, and J. Nigou Tsukamurella paurometabola Lipoglycan, a New Lipoarabinomannan Variant with Pro-inflammatory Activity J. Biol. Chem., May 28, 2004; 279(22): 22973 - 22982. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. J. C. Gibson, L. Eggeling, W. N. Maughan, K. Krumbach, S. S. Gurcha, J. Nigou, G. Puzo, H. Sahm, and G. S. Besra Disruption of Cg-Ppm1, a Polyprenyl Monophosphomannose Synthase, and the Generation of Lipoglycan-less Mutants in Corynebacterium glutamicum J. Biol. Chem., October 17, 2003; 278(42): 40842 - 40850. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |